img
ADVERTISEMENT
ADVERTISEMENT

Federal appeals court halts abortion pills sent by mail, prescribed via telehealth

The court’s decision applies nationwide and restores the previous FDA policy, which requires the pill to be distributed only through in-person clinics.

ADVERTISEMENT

The court’s decision applies nationwide and restores the previous FDA policy, which requires the pill to be distributed only through in-person clinics.

A federal appeals court on Friday blocked a 2023 Food and Drug Administration (FDA) policy that allowed the abortion pill mifepristone to be prescribed through telemedicine and delivered by mail.

A three-judge panel on the 5th Circuit Court of Appeals unanimously ruled in favor of a Louisiana challenge to the Biden-era policy, finding that it violated the state’s sovereignty.

“The regulation creates an effective way for an out-of-state prescriber to place the drug in the hands of Louisianans in defiance of Louisiana law,” the judges wrote. They found that the policy undermined state laws aimed at "protecting unborn human life" and has caused "irreparable harm."

The court’s decision applies nationwide and restores the previous FDA policy, which requires the pill to be distributed only through in-person clinics.

The Trump administration had argued that Louisiana lacked standing in the case and asked the court to pause proceedings while the FDA conducts a review of the drug. In April, a Louisiana district court granted the administration’s request to delay the case but ordered the FDA to quickly complete a safety review of mifepristone and provide the court with a report by October.

Louisiana appealed the ruling, arguing residents needed immediate relief from the increase in abortion pills being prescribed online by doctors in other states and sent into Louisiana.

Louisiana is one of several states seeking to challenge telehealth abortion access as states with abortion bans push back against expanded access to the drug. Idaho, Kansas, and Missouri have pursued similar efforts, while Texas and Florida have sought to ban Mifepristone altogether.

According to Politico, the Trump administration has continued to argue that states bringing these lawsuits lack standing and that the FDA should be allowed to complete its review process. However, Republican lawmakers have said they do not believe the agency is reviewing mifepristone in good faith. 
ADVERTISEMENT
ADVERTISEMENT
Sign in to comment

Comments

Powered by The Post Millennial CMS™ Comments

Join and support independent free thinkers!

We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.

Support The Post Millennial

Remind me next month

To find out what personal data we collect and how we use it, please visit our Privacy Policy

ADVERTISEMENT
ADVERTISEMENT
By signing up you agree to our Terms of Use and Privacy Policy
ADVERTISEMENT
© 2026 The Post Millennial, Privacy Policy